Viracta Therapeutics Inc - ESG Rating & Company Profile powered by AI
The ESG score covers 17 United Nations SDGs including: 'Clean Water & Sanitation', 'Climate Action' and 'Life below Water'. If you work at Viracta Therapeutics Inc and you would like to use your Sustainability rating, please get in touch. This webpage displays a zero-cost Environmental, Social and Governance analysis for Viracta Therapeutics Inc.
Viracta Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.7; made up of an environmental score of 2.0, social score of 0.0 and governance score of 3.2.
1.7
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1631 | Viewbix Inc | 1.8 | Low |
| 1631 | dorsaVi Ltd | 1.8 | Low |
| 1682 | Viracta Therapeutics Inc | 1.7 | Low |
| 1682 | C4 Therapeutics Inc | 1.7 | Low |
| 1682 | Abcellera Biologics Inc | 1.7 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Viracta Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Viracta Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Viracta Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Viracta Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Viracta Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Viracta Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Viracta Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Viracta Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Viracta Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Viracta Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Viracta Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Viracta Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Viracta Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Viracta Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Viracta Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Viracta Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Viracta Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Viracta Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Viracta Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Viracta Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Viracta Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Viracta Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Viracta Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Viracta Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Viracta Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Viracta Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Viracta Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Viracta Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Viracta Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Viracta Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Viracta Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Viracta Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Viracta Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Viracta Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Viracta Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Viracta Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Viracta Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket trial for the treatment of various relapsed/refractory Epstein-Barr virus-positive (EBV+) lymphoma, as well as an open-label Phase 1b/2 trial for the treatment of EBV+ recurrent or metastatic nasopharyngeal carcinoma and other EBV+ solid tumors. The company's development pipeline includes vecabrutinib, a clinical-stage non-covalent ITK/BTK inhibitor and VRx-510 (formerly SNS-510), a preclinical-stage PDK-1 inhibitor. It is evaluating development and collaboration opportunities for vecabrutinib in combination with chimeric antigen receptor T-cell therapies and VRx-510 in various oncology indications. The company was formerly known as Sunesis Pharmaceuticals, Inc. to Viracta Therapeutics, Inc. in February 25, 2021. Viracta Therapeutics, Inc. was incorporated in 1998 and is headquartered in Cardiff-by-the-Sea, California.